Eishi Baba
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and Retrovirus Studies
Papers in
- Oncology 105
- Colorectal Cancer Treatments and Studies 40
- Cancer Treatment and Pharmacology 24
- Cancer Immunotherapy and Biomarkers 17
-
- Gastric Cancer Management and Outcomes 28
- Lung Cancer Treatments and Mutations 15
- Co-authors
- Hitoshi Kusaba (79 shared papers)Hiroshi Ariyama (71 shared papers)Tsuneo FUKATA (12 shared papers)Koichi Akashi (77 shared papers)Akira Arakawa (13 shared papers)Kazumi Sasai (7 shared papers)Mine Harada (19 shared papers)Shuji Nakano (23 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (9 papers)Journal of Clinical Oncology (8 papers)Medicine (8 papers)Cancer Science (7 papers)Annals of Oncology (7 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Eishi Baba
182 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 112
- Oncology 1.2k
- Immunology 935
- Animal Science and Zoology 279
- Gastroenterology 149
- Agronomy and Crop Science 239
Countries citing papers authored by Eishi Baba
This map shows the geographic impact of Eishi Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eishi Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eishi Baba more than expected).
Fields of papers citing papers by Eishi Baba
This network shows the impact of papers produced by Eishi Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eishi Baba. The network helps show where Eishi Baba may publish in the future.
Co-authors
The 25 scholars most cited alongside Eishi Baba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 108 | |
| 2 | 2018 | 92 | |
| 3 | 2020 | 83 | |
| 4 | 2011 | 79 | |
| 5 | 1988 | 77 | |
| 6 | 2020 | 69 | |
| 7 | 2005 | 59 | |
| 8 | 1994 | 57 | |
| 9 | 2001 | 56 | |
| 10 | 2020 | 56 | |
| 11 | 1997 | 54 | |
| 12 | 2006 | 53 | |
| 13 | 2020 | 51 | |
| 14 | 1993 | 50 | |
| 15 | 2003 | 48 | |
| 16 | 2003 | 48 | |
| 17 | 1992 | 46 | |
| 18 | 2003 | 45 | |
| 19 | 2008 | 45 | |
| 20 | Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. | 2003 | 44 |
About Eishi Baba
Eishi Baba is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Surgery, having authored 194 papers that have together received 3.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (40 papers), Gastric Cancer Management and Outcomes (28 papers), Cancer Treatment and Pharmacology (24 papers), Cancer Immunotherapy and Biomarkers (17 papers), Immune Cell Function and Interaction (15 papers), Lung Cancer Treatments and Mutations (15 papers), Immunotherapy and Immune Responses (14 papers) and Coccidia and coccidiosis research (12 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (935 citations), Animal Science and Zoology (279 citations), Gastroenterology (149 citations) and Agronomy and Crop Science (239 citations). Eishi Baba has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Hitoshi Kusaba, Hiroshi Ariyama, Tsuneo FUKATA, Koichi Akashi, Akira Arakawa, Kazumi Sasai, Mine Harada, Shuji Nakano, Kenji Mitsugi and Taito Esaki. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Medicine, Cancer Science and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.